Award-winning Biotechnology and Pharmaceutical Sales Leader. Successful in driving market share, patient access, customer service expertise with physician, pharmaceutical and hospital staff. Revenue driver that increases market share, gaining competitive advantage, leading teams and training employees.
Overview
7
7
years of professional experience
Work History
Oncology Senior Biopharmaceutical Representative
AMGEN, INC.
Appointed as District Sales Trainer-Atlanta Orange OBU.
National, regional and district sales, leadership, and peer leadership accomplishments on 19 occasions, including Team Excellence four (4) times, Top 10% rankings, and District Impact.
Senior Nervous System Specialty Representative
PFIZER, INC.
Branch Manager, Branch Operations Specialist, Corporate Special Events Officer
NATIONS BANK
Manager, VAP Training and Talent Development-Hem/ONC/CAR-T
BRISTOL MYERS SQUIBB
09.2021 - 09.2023
Strategic business partner across the US Value, Access, and Pricing organization to provide innovative and flexible training solutions that align with HEM/ONC strategies, initiatives, and content to BMS organizational goals and Payer and Organized Customer Sales (POCS), as well as Strategic Payer Marketing (SPM) needs to improve field team performance in achieving access objectives.
Own project management activities relating to field training initiatives for VAP and regularly update the VAP leadership or respective business partners on the progress or potential delays.
In-depth knowledge of the evolving pharma market, disease state and healthcare landscape, payers, population health, account management practices, patient access journey across BMS/HEM/ONC therapeutic areas.
Lead without authority to partner with senior team leaders and foundational partners across a complex matrix organization.
In-depth knowledge and understanding of adult learning principles and instructional design to ensure learner-friendly training and to support POCS and SPM in the design or development of their prioritized training solutions and plans.
Facilitate learning in both live and virtual settings and ensure cross-functional best practices are shared.
Evaluate and provide constructive feedback on learning design documents and final deliverables.
Develop methods to measure the business impact of training activities.
Collaborate with the Above Brand training lead on integrating Brand HEM/ONC/CAR-T training into the Account Executive new hire onboarding program.
Oncology Account Specialist
IPSEN BIOPHARMACEUTICALS
06.2020 - 09.2021
Promote Somatuline Depot Injection for gastrointestinal neuroendocrine and pancreatic neuroendocrine tumors, to the medical oncology community of physicians, mid-levels, nurses, pharmacy, and account administrators (contracting, reimbursement).
Collaborate with Clinical Nurse Educator to pull through nursing education and product demonstration of Somatuline Depot and Onivyde for rare disease.
Demonstrate a high proficiency of the broader reimbursement environment; possess a deep understanding of the reimbursement and fulfillment pathways for injectable and infused medications.
Collaborate with the Reimbursement Director to engage accounts on status of health plan coverage, and services offered. Coordinate communication of reimbursement updates and access as relates to Somatuline Depot and Onivyde in hospital outpatient and community settings.
Collaborate with National and Regional Account Directors on contracting status and initiatives of Ipsen’s Somatuline Depot wholesaler accounts.
Ranked #1 in the Nation YTD thru 3/2020 out of 75 Oncology Account Specialists.
Key Account Manager
SAGE THERAPEUTICS
08.2018 - 04.2020
Identify and engage KOL support for ZULRESSO (post-partum depression), rare disease/orphan drug status.
Identify and develop hospital/IDN advisors/advocacy to address policy and business issues and formulary decisions.
Collaborate with Sales, National Account Directors, Trade, Marketing, HEOR, and Medical to build long-term strategic partnerships with targeted accounts.
Effectively translate how disease state and treatment options impact patients, payers, institutions, health systems and healthcare providers.
Participate in industry meetings to build business relevant relationships with the customer base.
Develop, implement, and manage regional strategic accounts.
Collaborate with field partners (TBS, RBD), corporate account directors and internal team to execute on strategies and pull through.
Problem solve and take appropriate risks to seek solutions.
Lead without authority to achieve necessary business objectives with internal and external stakeholders.
Lead cross functional team to identify key opportunities and develop specific market objectives, strategies, tactics, and action plans to achieve desired business outcomes.
Think critically to navigate complexities in patient care pathways and sites of care.
Ensure compliance with promotional activities and identify critical risk areas and develop mitigation strategies.
Build and leverage business relationships with key external stakeholders within strategic hospitals/health systems/sites of care to drive treatment acceptance/implementation (including C-Suite stakeholders).
105% attainment on Q3’19 MBO’s for ZULRESSO.
Oncology Sales Consultant
BAYER HEALTHCARE, LLC, TKI
03.2017 - 08.2018
Brand Ambassador for Nexavar and Stivarga for rare diseases to Community and Hospital Oncology providers.
Work in a collaborative effort to pull through on newly implemented target clinic account contracts.
Organize and implement speaker programming as well as Clinical Nurse Educator programming.
Increase account market share and threshold attainment through compliant messaging.
Add value to accounts and providers by uncovering what is most important to prescribing needs.
Uncover business growth opportunities for increased threshold attainment.
Seventh of fifty-eight nationally for Stivarga with 145% threshold attainment and 107% Nexavar.
Seventy-eight percent Stivarga growth within six months of completion of new hire training.
Fifth in the Nation of 52 Consultants in 2017 for Stivarga with 114% YTD attainment.